Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 

 
 

  Exhibit 4.25    
    

THE WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE "SECURITIES") HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS ("BLUE SKY LAWS"). NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS WARRANT OR THE
SECURITIES OR ANY INTEREST THEREIN MAY BE MADE EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE BLUE SKY LAWS OR (B) IF THE COMPANY
HAS BEEN FURNISHED WITH BOTH AN OPINION OF COUNSEL FOR THE HOLDER, WHICH OPINION AND COUNSEL SHALL BE SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT NO REGISTRATION IS REQUIRED BECAUSE OF THE
AVAILABILITY OF AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE BLUE SKY LAWS, AND ASSURANCES THAT THE TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION
WILL BE MADE ONLY IN COMPLIANCE WITH THE CONDITIONS OF ANY SUCH REGISTRATION OR EXEMPTION.

 
 

  FORM OF WARRANT
  FOR
  SHARES OF COMMON STOCK
  OF
  PROUROCARE MEDICAL INC.    
    

			
	Warrant No.             	 	 Golden Valley, Minnesota

October 31, 2008

        FOR
VALUE RECEIVED,                        , or his successors or assigns ("Holder"),
is entitled to subscribe for and purchase from ProUroCare
Medical Inc., a Nevada corporation (the "Company"), up to                          fully paid and
non-assessable shares of the Company's common stock, $0.00001 par value per share (the "Common Stock"), at the price of  $2.00 per share, subject to
adjustments as noted in section 3 below (the "Warrant Exercise
Price"). 

        This
warrant may be exercised by Holder at any time or from time to time on or prior to the fifth anniversary of the date hereof. 

        This
warrant is subject to the following provisions, terms and conditions: 

        1.    Exercise of Warrant.    The rights represented by this warrant may be exercised by the Holder, in whole or in
part, by written notice of exercise delivered to the Company at least three days prior to the intended date of exercise and by the surrender of this warrant (properly endorsed if required) at the
principal office of the Company and upon payment to it by cash, certified check or bank draft of the purchase price for such shares. The shares so purchased shall be deemed to be issued as of the
close of business on the date on which this warrant has been exercised by its surrender and payment to the Company of the Warrant Exercise Price. Certificates for the shares of stock so purchased,
bearing the restrictive legend set forth in Section 5 of this warrant, shall be delivered to the Holder within 15 days after the rights represented by this warrant shall have been so
exercised, and, unless this warrant has expired, a new warrant representing the number of shares, if any, with respect to which this warrant has not been exercised shall also be delivered to the
Holder within such time. No fractional shares shall be issued upon the exercise of this warrant. 

        2.    Certain Covenants of the Company.    The Company covenants and agrees that all shares that may be issued upon
the exercise of the rights represented by this warrant shall, upon issuance, be duly authorized and issued, fully paid and non-assessable shares. The Company further covenants and agrees
that during the period within which the rights represented by this warrant may be exercised, the Company will at all times have authorized, and reserved for the purpose of issue or transfer upon 

exercise
of the subscription rights evidenced by this warrant, a sufficient number of shares of Common Stock to provide for the exercise of the rights represented by this warrant. 

        3.    Adjustment of Exercise Price and Number of Shares.    The number of shares the Holder may purchase and the
Warrant Exercise Price shall be subject to adjustment from time to time as hereinafter provided in this section 3. 

        (a)    Stock Dividend, Stock Split or Stock Combination.    If the Company at any time divides the outstanding shares
of its Common Stock into a greater number of shares (whether pursuant to a stock split, stock dividend or otherwise), and conversely, if the outstanding shares of its Common Stock are combined into a
smaller number of shares, the Warrant Exercise Price in effect immediately prior to such division or combination shall be proportionately adjusted to reflect the reduction or increase in the value of
each such Common Stock. 

        (b)    Effect of Reorganization, Reclassification or Merger.    If any capital reorganization or reclassification of
the capital stock of the Company, or consolidation or merger of the Company with another corporation, or the sale of all or substantially all of its assets to another corporation shall be effected in
such a way that holders of the Common Stock shall be entitled to receive stock, securities or assets with respect to or in exchange for such Common Stock, then, as a condition of such reorganization,
reclassification, consolidation, merger or sale, the Holder shall have the right to purchase and receive upon the basis and upon the terms and conditions specified in this warrant and in lieu of the
shares of the Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights represented hereby, such shares of stock, other securities or assets as would have been
issued or delivered to the Holder if it had exercised this warrant and had received such shares of Common Stock prior to such reorganization, reclassification, consolidation, merger or sale. 

        (c)    Notice of Adjustment.    Upon any adjustment of the Warrant Exercise Price, the Company shall give written
notice thereof, by first class mail, postage prepaid, addressed to the registered Holder of this warrant at the address of such Holder as shown on the books of the Company, which notice shall state
the Warrant Exercise Price resulting from such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of this warrant, setting forth in
reasonable detail the method of calculation and the facts upon which such calculation is based. 

        4.    No rights as Shareholder.    This warrant shall not entitle the Holder to any voting rights or other rights as a
shareholder of the Company. 

        5.    Application of Restrictions of Transfer.    

        (a)   No
transfer of this warrant may be completed unless and until (i) the Company has received an opinion of counsel for the Company that such securities may be sold
pursuant to an exemption from registration under the Securities Act of 1933, as amended (the "Securities Act"), or (ii) a registration statement
relating to this warrant has been filed by the Company and declared effective by the Commission. Subject to the foregoing, this warrant and all rights hereunder are transferable, in whole or in part,
at the principal office of the Company by the Holder in person or by duly authorized attorney, upon surrender of this warrant properly endorsed to any person or entity who represents in writing that
he/she/it is acquiring the warrant for investment and without any view to the sale or other distribution thereof. Each Holder of this warrant, by taking or holding the same, consents and agrees that
the bearer of this warrant, when endorsed, may be treated by the Company and all other persons dealing with this warrant as the absolute owner hereof for any purpose and as the person entitled to
exercise the rights represented by this warrant or perform the obligations required hereby, or to the transfer hereof on the books of the Company, any notice to the contrary notwithstanding; but until
such transfer on such books, the Company may treat the registered owner hereof as the owner for all purposes. 

        (b)   In
no event shall the Holder(s) sell any shares of Common Stock that are issued upon the exercise of the rights represented by this warrant within 180 days
following the effective date of an initial public offering of the Common Stock of the Company. 

        (c)   Each
certificate for shares issued upon the exercise of the rights represented by this warrant shall bear a legend as follows unless, in the opinion of counsel to the
Company, such legend is not required in order to ensure compliance with the Securities Act: 

"THE SECURITIES EVIDENCED BY THIS CERTIFICATE WERE ISSUED, AND THE SECURITIES ISSUABLE IN CONNECTION WITH THE CONVERSION OF SUCH SECURITIES WILL BE ISSUED, IN A TRANSACTION
EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS, AND IN RELIANCE UPON THE HOLDER'S REPRESENTATION THAT SUCH SECURITIES WERE BEING
ACQUIRED FOR INVESTMENT AND NOT FOR RESALE. NO TRANSFER OF THE SECURITIES OR THE SECURITIES ISSUABLE IN CONNECTION WITH THE CONVERSION OF SUCH SECURTITIES MAY BE MADE ON THE BOOKS OF THE COMPANY
UNLESS (i) SUCH TRANSFER IS MADE PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS OR (ii) UNLESS
THE HOLDER SHALL HAVE PROVIDED THE COMPANY WITH AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO THE COMPANY TO THE EFFECT THAT NO SUCH REGISTRATION IS REQUIRED." 

        6.    Governing Law.    This Warrant shall be governed by and construed in accordance with the laws of the State of
Minnesota without regard to its conflicts-of-law provisions. 

        7.    Amendments and Waivers.    The provisions of this Warrant may not be amended, modified or supplemented, and
waiver or consents to departures from the provisions hereof may not be given, unless the Company agrees in writing and has obtained the written consent of the Holder. 

        8.    Successors and Assigns.    All the terms and conditions of this Warrant shall be binding upon and inure to the
benefit of the permitted successors and assigns of the Company and the Holder. 

        9.    Headings and References.    The headings of this Warrant are for convenience only and shall not affect the
interpretation of this Warrant. Unless the context indicates otherwise, all references herein to Sections are references to Sections of this Warrant. 

        10.    Notices.    All notices or communications hereunder, except as herein otherwise specifically provided, shall be
in writing. Notices sent to the Holder shall be mailed, hand delivered or faxed and confirmed to the Holder at his, her or its address set forth in the Company's records. Notices sent to the Company
shall be mailed, hand delivered or faxed and confirmed to ProUroCare Medical Inc., One Carlson Parkway, Suite 124, Plymouth, Minnesota 55447, or to such other address as the Company or
the Holder shall notify the other as provided in this Section. 

        IN
WITNESS WHEREOF, the Company has caused this warrant to be signed and delivered by its duly authorized officer. 

Dated:
October 31, 2008. 

					
	 	 	 PROUROCARE MEDICAL INC.:
	

 	
 	
 By:	
 	
 

 
	 	 	Name:  Richard C. Carlson

Title:    Chief Executive Officer

QuickLinks

Exhibit 4.25

FORM OF WARRANT FOR SHARES OF COMMON STOCK OF PROUROCARE MEDICAL INC.exhibit10a.htm

    EXHIBIT
10.A

    

    

    

    

    AMENDMENT
NO. 3 TO

    RECEIVABLES
PURCHASE AGREEMENT

    

    AMENDMENT
NO. 3, dated as of October 2, 2008, to the RECEIVABLES PURCHASE AGREEMENT
dated as of October 6, 2006 and amended by Amendment No. 1 dated as of
December 1, 2006 and Amendment No. 2 dated as of October 4, 2007 (the “Amended Agreement”), among
SNG FUNDING COMPANY, L.L.C., a Delaware limited liability company, SOUTHERN
NATURAL GAS COMPANY, a Delaware corporation, as initial Servicer, STARBIRD
FUNDING CORPORATION and the other funding entities from time to time party
hereto as Investors, BNP PARIBAS, NEW YORK BRANCH, and the other financial
institutions from time to time party hereto as Managing Agents, and BNP PARIBAS,
NEW YORK BRANCH, as Program Agent.

     

    Preliminary
Statement

     

    The
parties hereto have agreed to modify the Amended Agreement in certain respects
as set forth herein in accordance with Section 13.1 of the Amended
Agreement.

     

    NOW,
THEREFORE, in consideration of the premises and the mutual agreements herein
contained, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto hereby agree,
as follows:

     

    ARTICLE
1                 DEFINITIONS

     

    1.1    Definitions.  Unless
defined elsewhere herein, capitalized terms used in this Amendment shall have
the meanings assigned to such terms in the Amended Agreement, as amended
hereby.

     

    ARTICLE
2                 AMENDMENT

     

    2.1    Amendment to
Exhibit I.  Exhibit I to the Amended Agreement is
hereby amended as follows:

     

    (a)    To amend
and restate the definition of the term “Commitment Termination Date” contained
therein to read in its entirety as follows:

     

          “Commitment Termination Date”
means October 31, 2008, unless suchdate is extended with the consent of
the parties hereto.

     

    ARTICLE
3                MISCELLANEOUS

     

    3.1    Representations and
Warranties.

     

    (a)     Each
Seller Party hereby represents and warrants to the Program Agent, the Managing
Agents and the Investors, as to itself that the representations and warranties
of such Seller Party set forth in Section 5.1 of
the Amended Agreement are true and correct in all material respects on and as of
the date hereof as though made on and as of such date and after giving effect to
this Amendment; and

     

     

    
      
        
        

      

      
        {N0124647;
2}

        
          

        

      

      
        
        

      

    

     

    (b)   Seller
hereby represents and warrants to the Program Agent, the Managing Agents and the
Investors that, as of the date hereof and after giving effect to this Amendment,
no event has occurred and is continuing that constitutes an Amortization Event
or Potential Amortization Event.

     

    3.2    Effectiveness.  The
amendment set forth in Article 2 hereof shall be effective when this
Amendment or a counterpart hereof shall have been executed and delivered by
Seller, Servicer, the Managing Agents and the Program Agent and consented to by
the Conduit Investors and the Required Committed Investors.

     

    3.3    Amendments and
Waivers.  This Amendment may not be amended, supplemented or
modified nor may any provision hereof be waived except in accordance with the
provisions of Section 13.1 of the Amended Agreement.

     

    3.4    Counterparts.  This
Amendment may be executed in any number of counterparts and by different parties
hereto in separate counterparts, each of which when so executed shall be deemed
to be an original and all of which when taken together shall constitute one and
the same agreement.

     

    3.5     Continuing Effect; No Other
Amendments.  Except to the extent expressly stated herein, all
of the terms and provisions of the Amended Agreement are and shall remain in
full force and effect.  This Amendment shall not constitute a novation
of the Amended Agreement, but shall constitute an amendment
thereof.  This Amendment shall constitute a Transaction
Document.

     

    3.6     CHOICE OF
LAW.  THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING
SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT
OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES).

     

    [SIGNATURE
PAGES FOLLOW]

     

    

     

    
      
        
          

           

        

         

      

      
        
          2

          {N0124647;2}

        

        
          

        

      

      
         

      

    

    IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed
and delivered by their duly authorized officers as of the date
hereof.

     

    
    

    
      	 	SNG
      FUNDING COMPANY, L.L.C.
	 	 
	By: 	SNG
      Finance Company, L.L.C., its Manager 
	 	 
	By:	                                       
      /s/ John J. Hopper
	
               
      

            	
              Name:  John
      J. Hopper

            
	 	Title: 
      Authorized Signatory

    

     

     

    
      	 	SOUTHERN
      NATURAL GAS COMPANY, as Servicer
	 	 
	By:	/s/
      John J. Hopper 
	
               
      

            	
              Name:  John
      J. Hopper

            
	 	Title: 
      Authorized Signatory

    

     

     

    
      	 	BNP
      PARIBAS, acting through its New York Branch, as Program Agent and as
      Managing Agent for the Starbird Investor Group
	 	 
	By: 	/s/
      Samrah Kazmi
	
            	Name: 
      Samrah Kazmi
	 	Title: 
      Vice President 
	
               
      

            	
               

            
	 By:	/s/
      Philippe Mojon
	 	Name: 
      Philippe Mojon 
	 	Title: 
      Vice President 

    

     

     

    
      	 	CONSENTED
      TO:
	 	 
	
               
      

            	
              STARBIRD
      FUNDING CORPORATION,

            

    

    
      	
               
      

            	
              as
      a Conduit Purchaser

            

    

     

     

    
      	
              By:

            	
                                   
      /s/ Louise E. Colby

            	 

    

    
      	
               
      

            	
              Name:  Louise
      E. Colby

            

    

    
      	
               
      

            	
              Title:  Vice
      President

            

    

     

     

    
      
        
        

      

      
        
          [Signature
pages to Amendment No. 3 to

          SNG Receivables Purhase
Agrement]

          {N012467; 2}

        

        
          

        

      

      
        
        

      

    

     

    
      	
               
      

            	
              BNP
      PARIBAS, acting through its New York
Branch,

            

    

    
      	
               
      

            	
              as
      Committed Investor

            

    

     

     

    
      	
              By:

            	
                                  /s/
      Samrah Kazmi

            	 

    

    
      	
               
      

            	
              Name:  Samrah
      Kazmi

            

    

    
      	
               
      

            	
              Title:  Vice
      President

            

    

     

     

     

    
      	
              By:

            	
                                /s/
      Philippe Mojon

            	 

    

    
      	
               
      

            	
              Name:  Philippe
      Mojon

            

    

    
      	
               
      

            	
              Title:  Vice
      President

            

    

     

     

     

     

     

     

     

     

     

     

     

    
      [Signature
pages to Amendment No. 3 to

      SNG Receivables
Purhase Agrement]

      {N012467; 2}

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]